TipRanks
Go Ultimate55% OFF

Scinai Immunotherapeutics (2F50) Q1 2022 Earnings Report

0 Followers

DE:2F50 Q1 2022 EPS Results

Actual EPS
-EUR 0.45
Consensus EPS
EUR 0.00
Beat/Miss
Missed by -EUR 0.45
One Year Ago EPS
-EUR 0.55

DE:2F50 Q1 2022 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
EUR 0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q1 2022
Date
06/01/2022
Time
Before Open
Conference Call
Wednesday, June 1, 2022
DE:2F50 Upcoming Earnings

Scinai Immunotherapeutics's next earnings date is estimated for December 2, 2026, based on past reporting schedules.

Q1 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:2F50 Earnings History

DE:2F50 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Dec 02, 20262026 (Q3)―--42.3――
Aug 20, 20262026 (Q2)―-3.27-15.6779.16% (+12.41)
Jun 10, 20262026 (Q1)―0.00-7.1100.00% (+7.10)
Apr 01, 20262025 (Q4)―8.54-7.1220.31% (+15.64)
Dec 02, 20252025 (Q3)―-42.300.02-225919.05% (-42.32)
Sep 02, 20252025 (Q2)―-15.67-0.02-87750.00% (-15.66)
May 30, 20252025 (Q1)―-1.07-0.01-11840.00% (-1.06)
May 07, 20252024 (Q4)―-7.10-0.01-79480.00% (-7.09)
Nov 22, 20242024 (Q3)―0.020.18-89.50% (-0.16)
Aug 15, 20242024 (Q2)―--0.03―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed